Peter Crane

Peter Crane is a General Partner at Cambridge Innovation Capital, operating out of Cambridge, United Kingdom, where he directs seed and Series A investments. Before joining the firm in 2023, he served as an investment director at Oxford Science Enterprises, leveraging his academic foundation which includes a DPhil in Chemical Biology from the University of Oxford. Throughout his career, he has managed funds exceeding £200 million and built a portfolio of over 20 frontier technology companies, highlighted by the 2021 initial public offering of Exscientia. His recent transaction activity includes leading a £12 million Series A funding round for a PsiQuantum spinout in October 2024, alongside ongoing work with European frontier technology startups. Crane currently focuses on bridging complex scientific research with early-stage venture capital to scale deep tech, biotechnology, and quantum computing startups.